Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Report 2026

Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Overview

• Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows market size has reached to $1.82 billion in 2025 • Expected to grow to $4.51 billion in 2030 at a compound annual growth rate (CAGR) of 19.9% • Growth Driver: Surge In Adoption Of Precision Medicine Fueling The Growth Of The Market Due To Expanding Genomic Testing And Personalized Treatment • Market Trend: Advanced Single-Cell Genomics Solution Improves Regulatory Variant Identification • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market?

Single-cell expression quantitative trait locus (eQTL) clinical workflows are integrated processes that analyze gene expression variation at the single-cell level to identify expression quantitative trait loci (eQTLs) in clinical samples. These workflows combine single-cell sequencing technologies with computational and statistical methods to map how genetic variants influence cellular transcription profiles. They enable high-resolution insights into disease mechanisms, biomarker discovery, and personalized therapeutic strategies by linking genetic variation to functional cellular outcomes. The main workflow types of single-cell expression quantitative trait locus (eQTL) clinical workflows include sample preparation, library preparation, sequencing, data analysis, and other workflow types. Sample preparation refers to processes that isolate and prepare individual cells for downstream molecular analysis. The technologies include ribonucleic acid sequencing, microarray, polymerase chain reaction (PCR)-based methods, and other technologies. The key applications of disease research, drug discovery and development, personalized medicine, and other applications, while the end-users include hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end users.

What Is The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Growth Forecast?

The single-cell expression quantitative trait locus (eqtl) clinical workflows market size is expected to see rapid growth in the next few years. It will grow to $4.51 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to growth of ai-driven analysis tools, adoption of single-cell sequencing technologies, expansion of personalized medicine initiatives, integration with cloud-based platforms, automation of sample and library preparation. Major trends in the forecast period include single-cell sequencing integration, advanced computational analysis, high-resolution gene expression mapping, automated workflow pipelines, predictive biomarker discovery.

Global Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Segmentation

1) By Workflow Type: Sample Preparation, Library Preparation, Sequencing, Data Analysis, Other Workflow Types 2) By Technology: Ribonucleic Acid Sequencing, Microarray, Polymerase Chain Reaction (PCR)-Based, Other Technologies 3) By Application: Disease Research, Drug Discovery And Development, Personalized Medicine, Other Applications 4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Sample Preparation: Cell Isolation, Cell Sorting, Cell Lysis, Nucleic Acid Extraction, Quality Control Assessment 2) By Library Preparation: Ribonucleic Acid Fragmentation, Complementary Deoxyribonucleic Acid Synthesis, Adapter Ligation, Amplification, Library Quality Control 3) By Sequencing: Whole Transcriptome Sequencing, Targeted Sequencing, Single Cell Sequencing, High Throughput Sequencing, Paired End Sequencing 4) By Data Analysis: Read Alignment, Expression Quantification, Variant Calling, Expression Quantitative Trait Loci Mapping, Statistical Analysis 5) By Other Workflow Types: Data Integration, Validation Studies, Reporting And Documentation, Regulatory Compliance, Data Storage And Management

What Is The Driver Of The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market?

The rising adoption of precision medicine is expected to propel the growth of the single-cell expression quantitative trait locus (eQTL) clinical workflows market going forward. Precision medicine is a medical approach that tailors disease prevention, diagnosis, and treatment strategies to individual patient characteristics, including genetic makeup, lifestyle, and environment. The rise in adoption of precision medicine is increasing due to the rising global burden of complex and chronic diseases that require highly specific and individualized treatment strategies. Single-cell expression quantitative trait locus (eQTL) clinical workflows support the rising adoption of precision medicine by enabling high-resolution analysis of gene expression variations at the individual cell level, facilitating the identification of patient-specific therapeutic targets. They streamline complex genomic data processing and interpretation, reducing the time from sample collection to actionable insights, and enhancing personalized treatment strategies and clinical decision-making. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based educational and advocacy organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. Therefore, the rising adoption of precision medicine is driving the growth of the single-cell expression quantitative trait locus (eQTL) clinical workflows industry.

Key Players In The Global Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market

Major companies operating in the single-cell expression quantitative trait locus (eQTL) clinical workflows market are Thermo Fisher Scientific Inc., Becton Dickinson Company, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Standard BioTools Inc., Singleron Biotechnologies GmbH, Mission Bio Inc., Active Motif Inc., Admera Health LLC, Atrandi Biosciences UAB, SeqWell Inc., S2 Genomics Inc., Honeycomb Biotechnologies Inc., Roche Sequencing Solutions Inc., Cell Microsystems Inc.

Global Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Trends and Insights

Major companies operating in the single-cell expression quantitative trait locus (eQTL) clinical workflows market are focusing on developing innovative solutions, such as whole genome sequencing (WGS)-based eQTL workflow, to enable precise, cell-type–specific genetic analysis and advance personalized medicine. Whole genome sequencing (WGS)-based eQTL workflows are analytical approaches that integrate whole-genome sequencing data with gene expression data to identify genetic variants that regulate gene expression levels. For instance, in January 2023, according to the Singleron Biotechnologies Ltd., a Germany-based biotechnology company, launched a new single-cell eQTL analysis workflow as part of their sequencing service. It is a bioinformatic pipeline that leverages scRNA-seq and WGS data to predict cell-type-specific eQTLs, enabling researchers to investigate the association between genetic variation and gene expression levels at high resolution. This resource is ideal for customers conducting population studies and needing integrated wet lab and computational support, offering a streamlined solution to elucidate the molecular mechanisms of disease and complement Singleron's established single-cell multi-omics sequencing services.

What Are Latest Mergers And Acquisitions In The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market?

In November 2025, QIAGEN N.V., a Netherlands-based biotechnology company, acquired Parse Biosciences Inc. for approximately $225 million. With this acquisition, QIAGEN aims to expand its sample technologies portfolio into highly scalable, instrument-free single-cell sequencing solutions, strengthening its position in the rapidly growing single-cell market and accelerating AI-driven biological research and drug discovery capabilities. Parse Biosciences Inc. is a US-based company offering single-cell RNA‑seq solutions that provide high-resolution expression data for cell‑type-specific eQTL analysis in clinical research.

Regional Insights

North America was the largest region in the single-cell expression quantitative trait locus (eQTL) clinical workflows market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market?

The single-cell expression quantitative trait locus (eQTL) clinical workflows market consists of revenues earned by entities by providing services such as integrated single-cell sequencing workflows, high-resolution gene expression analysis, computational eQTL mapping, and secure genomic data management. The market value includes the value of related goods sold by the service provider or included within the workflow offering. The single-cell expression quantitative trait locus (eQTL) clinical workflows market includes sales of single-cell library preparation kits, microfluidic consumables, sequencing reagents, cell isolation platforms, barcoding and indexing kits, and specialized bioinformatics software for eQTL analysis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Single-Cell Expression Quantitative Trait Locus (eQTL) Clinical Workflows Market Report 2026?

The single-cell expression quantitative trait locus (eqtl) clinical workflows market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell expression quantitative trait locus (eqtl) clinical workflows industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.